Drug Profile
ITF 2534
Alternative Names: ITF-2534Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Italfarmaco
- Class Triazoles
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Aspergillosis; Cryptococcosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Aspergillosis in Italy (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cryptococcosis in Italy (PO)